Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Ireland

Marie Skłodowska-Curie Action · Finished

NANOINHALE Polypeptide hybrid nanoparticles for the delivery of inhalable drugs

Coordinator
Royal College of Surgeons in Ireland, Ireland
Runs
3 April 2023 to 2 April 2025
Status
Finished
EU funding
€200k
Total cost
—
Partners
1 organisations in 1 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101103989

What the project is doing

In the project's own words, from its summary on CORDIS.

Infectious respiratory diseases such as COVID or tuberculosis (TB) still have devastating effects on population health. While the development of potent vaccines has drastically reduced infection rates for some diseases, medicinal drugs remain a corner stone of treatment. Respiratory drug delivery via inhalation is considered an ideal way to directly target the site of infection in the lung. However, suitable functional polymeric drug carriers meeting all clinical and pharmaceutical requirements are rare.

NanoInhale aims to develop novel polypeptide nanoparticles with mucus penetrating and cell targeting properties suitable for nebuliser-based drug administration to the lower respiratory tract with a project proof-of-concept demonstration for tuberculosis (TB) up to in vitro level. This clinically informed project is placed at the intersection of polymer chemistry, biomaterial science, and drug delivery and further expands into the fields of medical devices and nanomedicine.

The project involves academic and clinical collaborators active in the fields of polymer and pharmaceutical science as well as TB Immunology. The applicants’ expertise in translational polymeric biomaterials in medical applications will be further enhanced by a unique training programme in scientific and complementary skills. NanoInhale’s impact goes beyond the studied area of TB as this platform technology is envisaged to be exploitable in other respiratory treatments.

Project results will be communicated to the scientific community as well as the public to create further awareness of the importance of combating infectious respiratory diseases.

Topics

Who is involved

OrganisationCityCountryRole
Royal College of Surgeons in IrelandDublin 2IrelandCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI